ZA200610140B - Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes - Google Patents

Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes

Info

Publication number
ZA200610140B
ZA200610140B ZA200610140A ZA200610140A ZA200610140B ZA 200610140 B ZA200610140 B ZA 200610140B ZA 200610140 A ZA200610140 A ZA 200610140A ZA 200610140 A ZA200610140 A ZA 200610140A ZA 200610140 B ZA200610140 B ZA 200610140B
Authority
ZA
South Africa
Prior art keywords
diabetes
treatment
benzamide derivatives
glk activators
heteroaryl benzamide
Prior art date
Application number
ZA200610140A
Other languages
English (en)
Inventor
Johnstone Craig
Mckerrecher Darren
Pike Kurt Gordon
Waring Michael James
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of ZA200610140B publication Critical patent/ZA200610140B/xx

Links

Classifications

    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
ZA200610140A 2004-06-05 2006-12-04 Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes ZA200610140B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB0412602.5A GB0412602D0 (en) 2004-06-05 2004-06-05 Compounds

Publications (1)

Publication Number Publication Date
ZA200610140B true ZA200610140B (en) 2009-03-25

Family

ID=32696738

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA200610140A ZA200610140B (en) 2004-06-05 2006-12-04 Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes

Country Status (4)

Country Link
CN (1) CN101018773A (ru)
GB (1) GB0412602D0 (ru)
UA (1) UA87685C2 (ru)
ZA (1) ZA200610140B (ru)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20120277208A1 (en) * 2009-12-11 2012-11-01 Astellas Pharma Inc. Benzamide compound

Also Published As

Publication number Publication date
UA87685C2 (ru) 2009-08-10
CN101018773A (zh) 2007-08-15
GB0412602D0 (en) 2004-07-07

Similar Documents

Publication Publication Date Title
IL179389A0 (en) Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
IL186865A0 (en) Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
IL188059A0 (en) Heteroaryl benzamide derivatives for use as glk activators in the treatment of diabetes
HK1258903A1 (zh) 抗-連接蛋白化合物及其治療應用
IL178151A0 (en) Sulfonamide-thiazolpyridine derivatives as glucokinase activators useful in the treatment of type 2 diabetes
HK1096092A1 (en) Benzamide derivatives and their use as glucokinase activating agents
IL213808A0 (en) Heteroaryl-ureas and their use as glucokinase activators
IL181235A0 (en) Substituted phenylacetamides and their use as glucokinase activators
IL177232A0 (en) Heteroarylaminopyrazole derivatives useful for the treatment of diabetes
ZA200801822B (en) Pyrazine derivatives and use as p13k inhibitors
IL182010A0 (en) Heteroaryl compounds for use as betamimetics in the treatment of respiratory diseases
ZA200710817B (en) Benzamide derivatives and uses related thereto
AP2007004157A0 (en) N- (N-sulfonylaminomethyl) cyclo-propanecarboxamide derivatives useful for the treatment of pain
IL180872A0 (en) Substituted 8-aminoalkylthio-xanthines, and the use thereof as inhibitors of the dipeptidyl peptidase iv
EP1713515A4 (en) TECHNETIUM AND RHENIUM-TO (HETEROARYL) COMPLEXES AND METHOD OF USE THEREOF
ZA200704154B (en) Substituted benzoquinolizines as DPP-IV inhibitors for the treatment of diabetes
ZA200800438B (en) N-(heteroaryl)-1-heteroarylalkyl-1H-indole-2-carboxamide derivatives, preparation and use thereof
ZA200709873B (en) Heteroaryl benzamide derivatives for use as GLK activators in the treatment of diabetes
PT1885716E (pt) Derivados do tiazole e uso destes
ZA200711105B (en) Novel physiological substance nesfatin substance relevant thereto, and use of the substances
IL184008A0 (en) 4-cycloalkyl-substituted tetrahydrochinoline derivatives and use thereof as medicaments
EP1750698A4 (en) 5-ANILINO-4-HETEROARYLPYRAZOLE DERIVATIVES USEFUL FOR THE TREATMENT OF DIABETES
PL1933840T3 (pl) Zastosowanie delmopinolu w leczeniu trądziku
IL190963A0 (en) Novel processes for the preparation of piperazinly and diazapanyl benzamide derivatives
ZA200706022B (en) Spiroketal derivatives and use thereof as diabetic medicine